Athernal Bio officially launches with £3.5 million funding from Delin Ventures to develop targeted immunotherapies for high-risk clonal haematopoiesis.
Amount Raised
£3.5 Million
Round Type
Funding Round
CambridgeBiotechnologyHealth CareInvestors
Description
Athernal Bio announced its launch with £3.5 million funding from founding investor Delin Ventures. This funding supports preclinical milestones as the company works towards clinical trials. Focused on immunotherapies for clonal haematopoiesis, it seeks to prevent blood cancers. Led by experienced founders, Athernal Bio aims to fill a gap in targeted treatments.
Quick answer
Athernal Bio raised £3.5 Million in a Funding Round round, dated October 1, 2025. Investors: Delin Ventures. Athernal Bio is based in Cambridge, England, United Kingdom.
- How much did Athernal Bio raise?
- Athernal Bio raised £3.5 Million in a Funding Round round on October 1, 2025.
- Who invested in Athernal Bio?
- Delin Ventures is named as investors in this round.
- What does Athernal Bio do?
- Athernal Bio is developing targeted immunotherapies to treat blood cancer precursor conditions before cancers become established.
- Where is Athernal Bio based and how big is it?
- Athernal Bio is based in Cambridge, England, United Kingdom. Fundz records about 6 employees.
- Who are the decision-makers at Athernal Bio?
- Fundz holds 1 contact at Athernal Bio, including the Chief Operating Officer (COO), Founding Team. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Athernal Bio that raised within 45 days of this round, from Fundz verified event records.
- Fang Oral Care raised $1.1M (Funding Round) on November 15, 2025.
- TandemAI raised $22M (Series A) on November 14, 2025.
- Equillium raised $50M (Funding Round) on November 13, 2025.
- 4TEEN4 raised $64M (Series C) on November 13, 2025.
- Gate Bioscience raised $65M (Series B) on November 13, 2025.
- Scripta Therapeutics raised $12M (Seed) on November 13, 2025.
Who to call at Athernal Bio, and when
A new round usually means Athernal Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Athernal Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Athernal Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Athernal Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Athernal Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Athernal Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.